Form 4: Adicet Bio Executive Receives Stock Grant
Insider Transaction (Form 4)
Lloyd Klickstein, Chief Medical Officer and a Director of Adicet Bio, Inc., received 18,300 shares of common stock on August 5, 2026.
Summary
- Grant/award: acquired 18,300 Stock Option (Right to Buy) on August 5, 2026; holds 18,300 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Lloyd Klickstein — Director, Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Grant/award | Stock Option (Right to Buy) | 18,300 | — | — | 18,300 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Grant/award (18,300 shares) |
Keywords
insider transaction, Form 4, ACET, Adicet Bio, Inc., neutral, Lloyd Klickstein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.